CellCarta Biosciences, Inc.
Global contract research organization (CRO) offering integrated laboratory services across immune monitoring, histopathology, proteomics, genomics, spatial and single-cell biology, bioinformatics, and sample logistics to support discovery through clinical development and companion diagnostic efforts.
Industries
N/A
Products
Cytometry analysis software
Comprehensive cytometry analysis platform for visualization, gating and standardized reporting of cytometry datasets.
Healthy-tissue proteomic reference database
Curated healthy-tissue proteomic reference used to prioritize neo-epitopes and interpret antigen-presentation data.
Cytometry analysis software
Comprehensive cytometry analysis platform for visualization, gating and standardized reporting of cytometry datasets.
Healthy-tissue proteomic reference database
Curated healthy-tissue proteomic reference used to prioritize neo-epitopes and interpret antigen-presentation data.
Services
Biomarker assay development and validation
End-to-end development and regulatory-oriented validation of biomarker assays across multiple platforms and sample types.
Mass spectrometry-based biomarker and PK services
Quantitative proteomics, targeted MS assays for biomarker quantification and pharmacokinetics, including affinity-reagent-free methods for ADC quantification.
Genomics and sequencing services
Digital PCR, qPCR, RNA sequencing and next-generation sequencing workflows for mutation detection, expression profiling and molecular characterization.
Histopathology and digital pathology services
Tissue-based biomarker analysis including IHC, IF, ISH, multiplex IHC and digital slide analysis provided to clinical standards.
Immune monitoring and cellular phenotyping
Comprehensive immune monitoring using flow cytometry, ELISpot/FluoroSpot, basophil activation tests and mass cytometry for pharmacodynamic and biomarker endpoints.
Bioinformatics and biostatistics
Integrated statistical analysis, data visualization, pathway analysis and machine-learning-based exploratory analysis tailored to study objectives.
Biomarker assay development and validation
End-to-end development and regulatory-oriented validation of biomarker assays across multiple platforms and sample types.
Mass spectrometry-based biomarker and PK services
Quantitative proteomics, targeted MS assays for biomarker quantification and pharmacokinetics, including affinity-reagent-free methods for ADC quantification.
Genomics and sequencing services
Digital PCR, qPCR, RNA sequencing and next-generation sequencing workflows for mutation detection, expression profiling and molecular characterization.
Histopathology and digital pathology services
Tissue-based biomarker analysis including IHC, IF, ISH, multiplex IHC and digital slide analysis provided to clinical standards.
Immune monitoring and cellular phenotyping
Comprehensive immune monitoring using flow cytometry, ELISpot/FluoroSpot, basophil activation tests and mass cytometry for pharmacodynamic and biomarker endpoints.
Bioinformatics and biostatistics
Integrated statistical analysis, data visualization, pathway analysis and machine-learning-based exploratory analysis tailored to study objectives.
Expertise Areas
- Biomarker development and regulatory validation
- Proteomics and quantitative mass spectrometry
- Immune monitoring and cellular phenotyping
- Genomics, qPCR and next-generation sequencing
Key Technologies
- Targeted mass spectrometry (MRM) and discovery proteomics
- Multiparametric flow cytometry and cell sorting
- Mass cytometry (high-parameter single-cell proteomics)
- ELISpot / FluoroSpot and intracellular cytokine staining (ICS)